Synaptogenix Inc (SNPX)

[Cyosol]

It makes more sense if you consider that most people either don't know about this company or don't expect it to succeed after failing to prove efficacy above placebo twice in a row.

If an approved AD drug is worth $20 billion and 99% of trials fail, then it would make sense that the first shot on goal is worth 1%, the second shot on goal is worth 0.5%, and the third shot on goal is worth 0.25%, which is $50 million.

A lot of people seem to believe that good results are worth $1 billion, which is strange to me because that would imply a 95% chance of failure.